Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Human heredity and Health (H3) in Africa kidney disease research network: a focus on methods in Sub-Saharan Africa

CKD affects an estimated 14% of adults in sub-Saharan Africa, but very little research has been done on the cause, progression, and prevention of CKD there. As part of the Human Heredity and Health in Africa (H3Africa) Consortium, the H3Africa Kidney Disease Research Network was established to study...

Full description

Saved in:
Bibliographic Details
Format: Article
Published: 2015
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000njm a2000000a 4500
001 oai:repository.ui.edu.ng:123456789/12181
042 |a dc 
720 |a Osafo, C.  |e author 
720 |a Raji, Y. R.  |e author 
720 |a Burke, D.  |e author 
720 |a Bamidele, O. T.  |e author 
720 |a Tiffin,N.  |e author 
720 |a Moxey-Mims, M. M.  |e author 
720 |a Rasooly, R. S.  |e author 
720 |a Kimmel, P. L.  |e author 
720 |a Ojo, A.  |e author 
720 |a Adu, D.  |e author 
720 |a Parekh, R. S.  |e author 
720 |a Ademola, A. D.  |e author 
260 |c 2015 
520 |a CKD affects an estimated 14% of adults in sub-Saharan Africa, but very little research has been done on the cause, progression, and prevention of CKD there. As part of the Human Heredity and Health in Africa (H3Africa) Consortium, the H3Africa Kidney Disease Research Network was established to study prevalent forms of kidney disease in sub-Saharan Africa and increase the capacity for genetics and genomics research. The study is performing comprehensive phenotypic characterization and analyzing environmental and genetic factors from nine clinical centers in four African countries (Ghana, Nigeria, Ethiopia, and Kenya) over a 5-year period. Approximately 4000 participants with specified kidney disease diagnoses and 4000 control participants will be enrolled in the four African countries. In addition, approximately 50 families with hereditary glomerular disease will be enrolled. The study includes both pediatric and adult participants age <1 to 74 years across a broad spectrum of kidney diseases secondary to hypertension-attributed nephropathy, diabetes, HIV infection, sickle cell disease, biopsy-proven glomerular disease, and CKD of unknown origin. Clinical and demographic data with biospecimens are collected to assess clinical, biochemical, and genetic markers of kidney disease. As of March 2015, a total of 3499 patients and controls have been recruited and 1897 had complete entry data for analysis. Slightly more than half (50.2%) of the cohort is female. Initial quality control of clinical data collection and of biosample and DNA analysis is satisfactory, demonstrating that a clinical research infrastructure can be successfully established in Africa. This study will provide clinical, biochemical, and genotypic data that will greatly increase the understanding of CKD in sub-Saharan Africa. 
024 8 |a 1555-905X 
024 8 |a ui_art_osafo_human_2015 
024 8 |a Clinical Journal of the American Society of Nephrology 10, pp. 2279–2287 
024 8 |a https://repository.ui.edu.ng/handle/123456789/12181 
653 |a Chronic Kidney Disease (CKD) 
653 |a H3Africa Kidney Disease Research Network 
653 |a Genetics and Genomics Research 
653 |a Sub-Saharan Africa 
653 |a Environmental and Genetic Factors 
245 0 0 |a Human heredity and Health (H3) in Africa kidney disease research network: a focus on methods in Sub-Saharan Africa